Financial Summary (All financials)
In millions, except per share items | Dec-31-02 | Dec-31-01 | Dec-31-00 | Dec-31-99 | Dec-31-98 | Dec-31-97 |
Revenues | 4,325 | 4,777 | 4,885 | 4,048 | 4,051 | 4,951 |
Revenue growth | -9.5% | -2.2% | 20.7% | -0.1% | -18.2% | |
Cost of goods sold | 3,643 | 4,132 | 4,155 | 3,375 | 3,206 | 3,862 |
Gross profit | 682 | 645 | 730 | 673 | 845 | 1,089 |
Gross margin | 15.8% | 13.5% | 14.9% | 16.6% | 20.9% | 22.0% |
Selling, general and administrative | 471 | 552 | 541 | 544 | 501 | 575 |
Research and development | 74 | 87 | 87 | 71 | 94 | 133 |
EBIT | 156 | -984 | 66 | -1,028 | 70 | 267 |
EBIT margin | 3.6% | -20.6% | 1.4% | -25.4% | 1.7% | 5.4% |
Pre-tax income | 60 | -238 | -34 | -412 | -145 | -45 |
Income taxes | -53 | 126 | -88 | 70 | -100 | -83 |
Tax rate | | | 258.8% | | 69.0% | 184.4% |
Net income | 187 | -385 | 58 | -207 | -44 | 47 |
Net margin | 4.3% | -8.1% | 1.2% | -5.1% | -1.1% | 0.9% |
|
Diluted EPS | $2.25 | ($7.23) | $1.01 | ($8.62) | ($0.80) | $0.68 |
Shares outstanding (diluted) | 50 | 50 | 53 | 56 | 56 | 56 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|